Disability and Adverse Effects of Oral Versus Long-Acting Injectable Antipsychotics in Schizophrenia-Spectrum and Bipolar Disorder: A Comparison Based on Data-Driven Taxonomy.
Rodolico A, Aprile SF, Cutrufelli P, Privitera G, Castellano S, Concerto C, Furnari R, Guerrera CS, Mineo L, Platania GA, Petralia A, Caraci F, Signorelli MS.
Rodolico A, et al.
Clin Drug Investig. 2024 Sep;44(9):715-727. doi: 10.1007/s40261-024-01391-x. Epub 2024 Sep 20.
Clin Drug Investig. 2024.
PMID: 39302586
Free PMC article.
RESULTS: The total sample consisted of 126 participants with a diagnosis of schizophrenia-spectrum or bipolar disorder, and included 54 males and 72 females ranging from 18 to 78 years of age (mean 45.1, standard deviation 14); 78 patients were taking oral antipsychotics and 48 w …
RESULTS: The total sample consisted of 126 participants with a diagnosis of schizophrenia-spectrum or bipolar disorder, and included 54 male …